High prevalence of undiagnosed iron deficiency in endometriosis patients: A cross‐sectional study
This study highlights the high prevalence of iron deficiency, which remains undiagnosed in over half of patients with endometriosis presenting to a gynecologist. Future research should focus on assessing the effectiveness of iron therapy in improving symptoms and overall well-being in this population.
Authors
- Sari Kives (ORCID: https://orcid.org/0000-0002-6914-7399)
- Klaudia Szczech (ORCID: https://orcid.org/0000-0002-7493-4557)
- Ally Murji (ORCID: https://orcid.org/0000-0002-4216-4172)
- Ann Kinga Malinowski (ORCID: https://orcid.org/0000-0002-3466-7570)
- Nadine Shehata (ORCID: https://orcid.org/0000-0002-9267-6256)
- Carmen McCaffrey (ORCID: https://orcid.org/0000-0001-9312-2768)
- Hanna R. Goldberg (ORCID: https://orcid.org/0000-0001-7198-0868)
- John Matelski
- Mara Sobel
- Nucelio Lemos (ORCID: https://orcid.org/0000-0002-3184-8229)
- Jonathon Solnik
Institutions
- Mount Sinai Hospital (CA)
- St. Michael's Hospital (CA)
- University of Toronto (CA)
- Trillium Health Centre (CA)
Publication Details
- Journal
- International Journal of Gynecology & Obstetrics
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1002/ijgo.15994
- Citations
- 5
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.69
Funders
- Pfizer
- Alexion Pharmaceuticals
- University of Toronto
- LEO Pharma